Clove Flower Extract (Syzygium aromaticum) Has Anticancer Potential Effect Analyzed by Molecular Docking and Brine Shrimp Lethality Test (BSLT)

Table 1

Crystal structures were used.

No	Access code PDB	Description	Resolution	Reference (DOI)
1	2JF9	Estrogen receptor alpha LBD in complex with a tamoxifen-specific peptide antagonist	2.10 Å	10.1074/jbc.M611 424200
2	1HOV	Solution structure of a catalytic domain of MMP-2 complexed with SC-74020	NMR	10.1016/s0167-4838(02)00307–2
3	1UK0	Crystal structure of the catalytic domain of human poly (ADP-ribose) polymerase with a novel inhibitor	3.00 Å	10.1016/s0014-5793(03)01362–0
4	2A4L	Human cyclin-dependent kinase 2 in complex with roscovitine	2.40 Å	10.1111/j.1432–1033.1997.0518a.x
5	2R0U	Crystal structure of Chek1 in complex with inhibitor 54	1.90 Å	10.1016/j.bmcl.2007.09.007
6	2 × 7F	Crystal structure of the kinase domain of human Traf2- and nck- interacting kinase with Wee1Chk1 inhibitor	2.80 Å	—
7	3E7G	Structure of human INOSOX with inhibitor AR-C95791	2.20 Å	10.1038/nchembio. 115
8	3RUK	Human cytochrome P450 CYP17A1 in complex with abiraterone	2.60 Å	10.1038/nature107 43
9	4LXD	Bcl_2-navitoclax analog (without thiophenyl) complex	1.90 Å	10.1038/nm.3048
10	6GUE	CDK2/CyclinA in complex with AZD5438	1.99 Å	10.1016/j.chembio l.2018.10.015